Effect of drug industry marketing practices on formularies questioned by federal agencies.
B
B
Gatty
D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004465:Economic Competition / Q000331:legislation & jurisprudence; D005572:Formularies, Hospital as Topic; D013006:Growth Hormone / Q000031:analogs & derivatives / Q000191:economics; D006801:Humans; D008329:Managed Care Programs / Q000191:economics / Q000331:legislation & jurisprudence; D011994:Recombinant Proteins / Q000191:economics; D014481:United States; D014485:United States Federal Trade Commission; D014486:United States Food and Drug Administration